Eli Lilly & Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2024
Total Assets: $78.72B
Liabilities Breakdown FY2024
Total Liabilities: $64.44B
Asset Breakdown
Total Assets: $78.72B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.27B | 4.2% |
| Accounts Receivable | $11.01B | 14.0% |
| Inventory | $7.59B | 9.6% |
| Property, Plant & Equipment | $17.10B | 21.7% |
| Goodwill | $5.77B | 7.3% |
| Intangible Assets | $6.17B | 7.8% |
| Other Assets | $27.81B | 35.3% |
Liabilities Breakdown
Total Liabilities: $64.44B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.23B | 5.0% |
| Long-Term Debt | $28.53B | 44.3% |
| Other Liabilities | $32.69B | 50.7% |